Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

News > All

Total search results: 4610 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 25 26 27 ... 45 46 47  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Miltenyi Biotec GmbH. (2/26/18). "Press Release: MolMed and Miltenyi Biotec. EMA Approves the Utilization of the CliniMACS Prodigy Equipment". Milan & Bergisch Gladbach. 2018-02-26
AiCuris Anti-infective Cures GmbH. (2/23/18). "Press Release: AiCuris’ Licensee MSD Launches Prevymis (letermovir) in Germany". Wuppertal. 2018-02-23
Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel. 2018-02-23
BCNP Consultants GmbH. (2/23/18). "Press Release: More than 1,200 Meetings at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-02-23
Qiagen N.V.. (2/23/18). "Press Release: Qiagen Opens Shared Services Center in Taguig City, Manila". Manila. 2018-02-23
Streck, Inc.. (2/23/18). "Press Release: Streck, Inc. Files Suit against Cenata GmbH for Infringement of Its European Patent". La Vista, NE. 2018-02-23
BRAIN AG. (2/22/18). "Press Release: BRAIN AG Expands Patent Protection for Unique Taste Cell Technology to Europe". 2018-02-22
Bruker Corporation. (2/22/18). "Press Release: Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM²". Ettlingen. 2018-02-22
Medigene AG. (2/21/18). "Press Release: Medigene Receives Approvals for Its First Clinical Trial with TCR Therapy MDG1011". Planegg. 2018-02-21
Basilea Pharmaceutica Ltd.. (2/21/18). "Press Release: Basilea's CEO Ronald Scott Will Retire. Chief Commercial Officer David Veitch Named as Successor – Changes in the Board of Directors". Basel. 2018-02-21
Bruker Corporation. (2/21/18). "Press Release: Bruker Announces Resignation of Chief Financial Officer and Appointment of Principal Accounting Officer". Billerica, MA. 2018-02-21
G1 Therapeutics, Inc.. (2/21/18). "Press Release: G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights". Research Triangle Park, NC. 2018-02-21
Merck KGaA. (2/21/18). "Press Release: Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia". Darmstadt. 2018-02-21
Cullinan Oncology, LLC. (2/20/18). "Press Release: Cullinan Oncology and MAB Discovery Announce Collaboration to Develop Novel Antibody-Based Therapeutics". Cambridge, MA & Neuried. 2018-02-20
Bruker Corporation. (2/20/18). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. 2018-02-20
Minoryx Therapeutics S.L.. (2/20/18). "Press Release: Minoryx Therapeutics Spins Off SEE-Tx Platform into New Company, Gain Therapeutics". Mataró, Barcelona & Lugano. 2018-02-20
Siemens AG. (2/19/18). "Press Release: Siemens Plans IPO of Siemens Healthineers AG in the First Half of Calendar Year 2018 [Not for United States, Australia, Canada or Japan]". Erlangen & Munich. 2018-02-19
Avillion LLP. (2/16/18). "Press Release: Avillion Advances Co-development Programme with Merck. IND Now Open for Phase 2 Study of M1095, an anti-IL-17 A/F Nanobody in Psoriasis". London. 2018-02-16
Pieris Pharmaceuticals, Inc.. (2/16/18). "Press Release: Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares". Boston, MA. 2018-02-16
Affimed N.V.. (2/15/18). "Press Release: Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. 2018-02-15
Addex Therapeutics S.A.. (2/15/18). "Press Release: Addex Launches CHF40 million Capital Increase with Commitments from Specialist US Healthcare Investors". Geneva. 2018-02-15
Roche. (2/15/18). "Press Release: Roche to Acquire Flatiron Health to Accelerate Industry-wide Development and Delivery of Breakthrough Medicines for Patients with Cancer". Basel. 2018-02-15
Merck KGaA. (2/15/18). "Press Release: Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer [Not intended for UK-based media]". Darmstadt. 2018-02-15
ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. 2018-02-15
Cell Medica Ltd.. (2/15/18). "Press Release: Cell Medica Announces the Appointment of Kevin Boyle as Chief Financial Officer". 2018-02-15
Bruker Corporation. (2/14/18). "Press Release: The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology". Billerica, MA. 2018-02-14
Recipharm AB. (2/14/18). "Press Release: Recipharm Appoints President Development Services to Drive End to End Offering". 2018-02-14
Affimed N.V.. (2/13/18). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. 2018-02-13
Gilde Healthcare Partners. (2/13/18). "Press Release: Gilde Healthcare Company RAD-x Continues Buy & Build with Acquisition of Swiss Medical Imaging Centers". Utrecht. 2018-02-13
Sciomics GmbH. (2/12/18). "Press Release: Sciomics Participates in Collaborative Clinical Trials for the Treatment of Metaphyseal Chondrodysplasia Type Schmid (MCDS)". Heidelberg. 2018-02-12
Affimed N.V.. (2/12/18). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. 2018-02-12
Lonza Group AG. (2/12/18). "Press Release: Lonza Expands Cell-Culture Portfolio with Quasi Vivo System". Basel. 2018-02-12
Pieris Pharmaceuticals, Inc.. (2/9/18). "Press Release: Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration". Boston, MA & Bothell, WA. 2018-02-09
Boehringer Ingelheim. (2/9/18). "Press Release: Boehringer Ingelheim Refocuses PDE9 Inhibition Brain Research on Schizophrenia Following Results from Phase II Alzheimer’s Trials". Ingelheim. 2018-02-09
Bruker Corporation. (2/8/18). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2017 Financial Results". Billerica, MA. 2018-02-08
Fluidigm Corporation. (2/8/18). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress". South San Francisco, CA. 2018-02-08
Genedata AG. (2/8/18). "Press Release: Genedata Bioprocess Licensed to Pfizer Inc.". Basel. 2018-02-08
Lonza Group Ltd.. (2/8/18). "Press Release: Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines". Basel & South San Francisco, CA. 2018-02-08
University of Bayreuth. (2/8/18). "Press Release: Innovative Research Infrastructure with a Global Reputation. The Northern Bavarian NRM Centre Repositions Itself". 2018-02-08
c-LEcta GmbH. (2/8/18). "Press Release: c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company". 2018-02-08
Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. 2018-02-07
Addex Therapeutics S.A.. (2/7/18). "Press Release: Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management". Geneva. 2018-02-07
Analytik Jena AG. (2/7/18). "Press Release: Laboratory Automation Solution Designed to Boost Productivity Showcased at SLAS 2018". San Diego, CA & Jena. 2018-02-07
Lonza Group Ltd.. (2/7/18). "Press Release: Lonza Partners with Prolog Ventures to Establish VC Fund to Invest in Consumer Health and Wellness Startups". Basel. 2018-02-07
Sanofi S.A.. (2/7/18). "Press Release: Sanofi Delivers 2017 Business EPS(1) in Line with Guidance". Paris. 2018-02-07
ProBioGen AG. (2/7/18). "Press Release: ProBioGen and Teva Sign License Agreement on Human Artificial Lymph Node Technology". Berlin. 2018-02-07
ImmunoQure AG. (2/6/18). "Press Release: Servier and ImmunoQure AG Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody". Paris & Düsseldorf. 2018-02-06
Genedata AG. (2/6/18). "Press Release: Genedata Announces New Solution for NGS-Based Biosafety Assessment". Basel. 2018-02-06
Idorsia Ltd.. (2/6/18). "Press Release: Idorsia Announces Financial Results for 2017 – Company Off to a Great Start – 4 Compounds to Enter Phase 3 Development". Allschwil. 2018-02-06
InflaRx N.V.. (2/6/18). "Press Release: InflaRx Announces Appointment of Tony Gibney to Its Board of Directors". Jena. 2018-02-06
Selvita S.A.. (2/6/18). "Press Release: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer". Kraków. 2018-02-06
Sophia Genetics S.A.. (2/6/18). "Press Release: Sophia Genetics Announces CE-IVD Marking of Its Genomic Test for Leukemia Detection". Lausanne. 2018-02-06
Faron Pharmaceuticals Oy. (2/5/18). "Press Release: Faron Establishes Second Traumakine Manufacturing Site". Turku. 2018-02-05
Addex Therapeutics S.A.. (2/5/18). "Press Release: Addex Provides Key Financial Indicators and Trading Update. Cash Position of CHF6.5 million as of 31 January 2018". Geneva. 2018-02-05
SGS S.A.. (2/2/18). "Press Release: SGS Acquires TraitGenetics GmbH, Germany". 2018-02-02
Genedata AG. (2/2/18). "Press Release: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer". Basel. 2018-02-02
4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. 2018-02-01
Medigene AG. (2/1/18). "Press Release: Medigene Strengthens Its Patent Portfolio with a US Patent on a Tagged TCR". Planegg. 2018-02-01
Lab Automation Network (LAN). (2/1/18). "Press Release: Cytosurge AG and Lab Automation Network Announce Partnership for Automated Single-cell Biology Applications". 2018-02-01
Life Science Inkubator GmbH. (2/1/18). "Press Release: Life Science Inkubator (LSI) Bonn for the First Time Supports Pharma Industry Spin-out". 2018-02-01
Miltenyi Biotec GmbH. (2/1/18). "Press Release: Cancer Coaching for the Immune System. Novel Cell Therapy Will Teach Immune Cells How to Fight Cancer". Teterow. 2018-02-01
Arnold & Porter LLP. (2/1/18). "Press Release: Announcing Arnold & Porter". 2018-02-01
Affimed N.V.. (2/1/18). "Press Release: Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas". Heidelberg. 2018-02-01
Qiagen N.V.. (1/31/18). "Press Release: Qiagen Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing". Germantown, MD & Hilden. 2018-01-31
Genedata AG. (1/31/18). "Press Release: Genedata Announces Genedata Screener for Massive Mechanistic Analysis". Basel. 2018-01-31
Analytik Jena AG. (1/31/18). "Press Release: SLAS 2018 — Modular Liquid Handling System CyBio FeliX Automates New Process for Nucleic Acid Extraction". Jena. 2018-01-31
Lonza Group AG. (1/31/18). "Press Release: Lonza Reports Record-breaking Full-year Results with Double-digit Lonza Standalone Sales Growth and More than 26% CORE EBIT Growth in a Major Transformational Year". Basel. 2018-01-31
Sanofi S.A.. (1/31/18). "Press Release: Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment". Paris & Geneva. 2018-01-31
AiCuris Anti-infective Cures GmbH. (1/31/18). "Press Release: Approval of MSD’s Prevymis (letermovir) by the European Commission Triggers the Next EUR 30 Million Milestone Payment for AiCuris". Wuppertal. 2018-01-31
Oncgnostics GmbH. (1/31/18). "Press Release: Reliable Test for Cervical Cancer Triage Now Available in Slovakia and the Czech Republic". Jena. 2018-01-31
Rentschler Biopharma SE. (1/31/18). "Press Release: Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer". Laupheim. 2018-01-31
Helsinn Healthcare S.A.. (1/30/18). "Press Release: Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement". Lugano. 2018-01-30
Creathor Venture Management GmbH. (1/30/18). "Press Release: Creathor Invests in E-Health Platform »Humanoo«". Berlin & Bad Homburg v.d.H.. 2018-01-30
BaseLaunch ( (1/30/18). "Press Release: BaseLaunch up to a Solid Phase II Start". Basel. 2018-01-30
Sanofi S.A.. (1/29/18). "Press Release: Sanofi to Acquire Ablynx for €3.9 Billion". Paris & Ghent. 2018-01-29
Merck KGaA. (1/26/18). "Press Release: Dirk Toepfer Joins Merck as Chief Information Officer". Darmstadt. 2018-01-26
Endress+Hauser AG. (1/26/18). "Press Release: Further Growth for Endress+Hauser in China. Third Plant Inaugurated in Suzhou". 2018-01-26
Novartis AG. (1/26/18). "Press Release: Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors". Basel. 2018-01-26
Santhera Pharmaceuticals Holding AG. (1/26/18). "Press Release: Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone in Duchenne Muscular Dystrophy". Liestal. 2018-01-26
Roche. (1/26/18). "Press Release: CHMP Recommends EU Approval of Roche’s Hemlibra for People with Haemophilia A with Inhibitors". Basel. 2018-01-26
Illumina, Inc.. (1/26/18). "Press Release: Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. 2018-01-26
ThromboGenics N.V.. (1/26/18). "Press Release: Novartis Pharma AG Holding 5.69% of ThromboGenics Equity Capital". Leuven. 2018-01-26
Clariant. (1/25/18). "Press Release: SABIC Acquires 24.99% Stake in Clariant. SABIC Acquires Stakes Previously Held by 40 North and Corvex Management". Muttenz. 2018-01-25
PerkinElmer, Inc.. (1/25/18). "Press Release: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017". Waltham, MA. 2018-01-25
Topas Therapeutics GmbH. (1/25/18). "Press Release: Topas Therapeutics Serves as Exclusive Translational Partner for Collaborative Research Center Focused on Liver Inflammation at University Medical Center Hamburg-Eppendorf". Hamburg. 2018-01-25
Novartis AG. (1/24/18). "Press Release: Novartis Delivered Good Operational Performance and Landmark Innovation in 2017, Entering Our Next Growth Phase". Basel. 2018-01-24
Novartis AG. (1/24/18). "Press Release: Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss". Basel. 2018-01-24
ImmuPharma plc. (1/24/18). "Press Release: Successful Placing to Raise £10 Million". 2018-01-24
Qlucore AB. (1/24/18). "Press Release: Enhanced Collaboration between Qlucore and Nebion to Help Biologists Get More Out of Their Data Analysis". 2018-01-24
CureVac AG. (1/24/18). "Press Release: CureVac Expands Intellectual Property Position that Significantly Improves Protein Expression for its mRNA-Based Vaccines and Therapeutics". Tübingen. 2018-01-24
Genedata AG. (1/24/18). "Press Release: Genedata, HighRes Biosolutions, and Titian Software Collaborate for Automated End-to-End Screening Solution". Basel, Beverly, CA & London. 2018-01-24
Ablynx N.V.. (1/24/18). "Press Release: Ablynx Appoints Dr Robert Friesen as Chief Scientific Officer". Ghent. 2018-01-24
Qiagen N.V.. (1/23/18). "Press Release: Qiagen Receives FDA Clearance for First-ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms". Hilden & Germantown, MD. 2018-01-23
High-Tech Gründerfonds Management GmbH. (1/23/18). "Press Release: Dräger Invests in HTGF III". 2018-01-23
BCNP Consultants GmbH. (1/22/18). "Press Release: 23rd February Chemistry Industry Innovators from 27 Countries Will Meet at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-01-22
Celgene Corporation. (1/22/18). "Press Release: Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy". Summit, NJ & Seattle, WA. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Completes Tender Offer for Advanced Accelerator Applications S.A. and Announces Commencement of Subsequent Offering Period". Basel. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Reports Erenumab Met All Primary and Secondary Endpoints in Unique Phase IIIb Study in Episodic Migraine Patients Who Have Failed Multiple Prior Preventive Treatments". Basel. 2018-01-22
Genmab A/S. (1/22/18). "Press Release: Genmab Announces Novartis' Intention to Transition Arzerra (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets". Copenhagen. 2018-01-22
Sanofi S.A.. (1/19/18). "Press Release: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee". Paris. 2018-01-19
next pagenext page 1 2 3 ... 25 26 27 ... 45 46 47  next pagenext page


Picture Berlin Partner Hotspot for Startups 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] No Content Marketing 650x80px

» top